In summary, in ascites from patients with gastric cancer, the LysoPA levels might be determined largely by its precursors, such as LysoPC and LysoPI, and LysoPS might be produced via a PS-PLA1-mediated pathway to a greater degree than in ascites from patients with cirrhosis. The gene discussed is POU2F3; the disease is gastric cancer.